Iron and Neurodegeneration in Multiple Sclerosis

Increased iron deposition might be implicated in multiple sclerosis (MS). Recent development of MRI enabled to determine brain iron levels in a quantitative manner, which has put more interest on studying the role of iron in MS. Evidence for abnormal iron homeostasis in MS comes also from analyses of iron and iron-related proteins in CSF and blood and postmortem MS brain sections. However, it is not yet clear if iron accumulation is implicated in MS pathology or merely reflects an epiphenomenon. Further interest has been generated by the idea of chronic cerebrospinal venous insufficiency that might be associated with brain iron accumulation due to a reduction in venous outflow, but its existence and etiologic role in MS are currently controversially debated. In future studies, combined approaches applying quantitative MRI together with CSF and serum analyses of iron and iron-related proteins in a clinical followup setting might help to elucidate the implication of iron accumulation in MS.

[1]  F. Paul,et al.  No cerebrocervical venous congestion in patients with multiple sclerosis , 2010, Annals of neurology.

[2]  J W Langston,et al.  The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. , 1999, Magnetic resonance imaging.

[3]  P. Zamboni.  The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006, Journal of the Royal Society of Medicine.

[4]  S. LeVine,et al.  The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.

[5]  J. R. Mitchell,et al.  Deep grey matter `black T2` on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis , 2007, Multiple sclerosis.

[6]  H. Schipper,et al.  Proinflammatory cytokines promote glial heme oxygenase‐1 expression and mitochondrial iron deposition: implications for multiple sclerosis , 2001, Journal of neurochemistry.

[7]  L. Rashed,et al.  The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study , 2008, Multiple sclerosis.

[8]  G. Giovannoni,et al.  Cerebrospinal fluid levels of brain specific proteins in optic neuritis , 2004, Multiple sclerosis.

[9]  S Ropele,et al.  Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis , 2009, Multiple sclerosis.

[10]  Helen Nichol,et al.  Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X‐ray fluorescence , 2010, Journal of magnetic resonance imaging : JMRI.

[11]  R. Bakshi,et al.  Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.

[12]  F. Barkhof,et al.  Chronic cerebrospinal venous insufficiency and multiple sclerosis , 2010, Annals of neurology.

[13]  A. Wåhlin,et al.  Venous and cerebrospinal fluid flow in multiple sclerosis: A case‐control study , 2010, Annals of neurology.

[14]  S. Lynch,et al.  A multiple course trial of desferrioxamine in chronic progressive multiple sclerosis. , 2000, Cellular and molecular biology.

[15]  R. Bakshi,et al.  Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening. , 2007, Radiology.

[16]  Ferdinand Schweser,et al.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.

[17]  E. Morgan,et al.  Iron trafficking inside the brain , 2007, Journal of neurochemistry.

[18]  C. Morris,et al.  Brain iron homeostasis. , 1992, Journal of inorganic biochemistry.

[19]  S. LeVine,et al.  Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis , 2007, Multiple sclerosis.

[20]  Rohit Bakshi,et al.  Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis , 2010, Multiple sclerosis.

[21]  J. Parratt,et al.  Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions , 2009, Annals of neurology.

[22]  E M Haacke,et al.  Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. , 2010, International angiology : a journal of the International Union of Angiology.

[23]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[24]  J. Gutteridge,et al.  Iron and oxygen radicals in brain , 1992, Annals of neurology.

[25]  S. LeVine,et al.  Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice , 1998, Journal of Neuroimmunology.

[26]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[27]  G. Salvador.  Iron in neuronal function and dysfunction , 2010, BioFactors.

[28]  Jan Sedlacik,et al.  Susceptibility weighted imaging at ultra high magnetic field strengths: Theoretical considerations and experimental results , 2008, Magnetic resonance in medicine.

[29]  C. Polman,et al.  Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. , 2009, Brain : a journal of neurology.

[30]  F. Salvi,et al.  Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. , 2010, International angiology : a journal of the International Union of Angiology.

[31]  J A Helpern,et al.  Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging , 2007, American Journal of Neuroradiology.

[32]  H. Hartung,et al.  Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency , 2011, Neurology.

[33]  E. Hatzimichael,et al.  Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients , 2005, Multiple sclerosis.

[34]  Maria Grazia Bruzzone,et al.  Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. , 2009, Radiology.

[35]  C. Polman,et al.  Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. , 2002, Brain : a journal of neurology.

[36]  G. Giovannoni,et al.  Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis , 2008, Multiple sclerosis.

[37]  S. Lynch,et al.  Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients , 1999, Brain Research.

[38]  D. Richardson.  Novel Chelators for Central Nervous System Disorders That Involve Alterations in the Metabolism of Iron and Other Metal Ions , 2004, Annals of the New York Academy of Sciences.

[39]  R. Bakshi,et al.  T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.

[40]  S. Nelson,et al.  Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron , 2008, Annals of neurology.

[41]  M. Fukunaga,et al.  Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast , 2010, Proceedings of the National Academy of Sciences.

[42]  R Bakshi,et al.  MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation , 2000, Neuroreport.

[43]  J. R. Mitchell,et al.  3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing–remitting multiple sclerosis: A 3-year pilot study , 2010, Journal of the Neurological Sciences.

[44]  F. Salvi,et al.  Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[45]  Paolo Zamboni,et al.  Anomalous Venous Blood Flow and Iron Deposition in Multiple Sclerosis , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  C. Guttmann,et al.  Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[47]  B. Drayer,et al.  Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? , 1987, AJR. American journal of roentgenology.

[48]  C. W. Tjoa,et al.  MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[49]  S. Ropele,et al.  Quantitative MR imaging of brain iron: a postmortem validation study. , 2010, Radiology.

[50]  R. Bakshi,et al.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.

[51]  D. Kell.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases , 2008, BMC Medical Genomics.

[52]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[53]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[54]  M. Filippi,et al.  T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis , 2009, Multiple sclerosis.

[55]  R. Solomons,et al.  Iron Status in Children With Recurrent Episodes of Tumefactive Cerebral Demyelination , 2010, Journal of Child Neurology.

[56]  Yi Wang,et al.  Quantitative MR susceptibility mapping using piece‐wise constant regularized inversion of the magnetic field , 2008, Magnetic resonance in medicine.

[57]  B. Mädler,et al.  MR relaxation in multiple sclerosis. , 2009, Neuroimaging clinics of North America.

[58]  D. Richardson,et al.  Iron: a new target for pharmacological intervention in neurodegenerative diseases. , 2006, Seminars in pediatric neurology.

[59]  J R Reichenbach,et al.  High-Resolution MR Venography at 3.0 Tesla , 2000, Journal of computer assisted tomography.

[60]  J. Schenck.  The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. , 1996, Medical physics.

[61]  Ya Ke,et al.  Brain iron metabolism: Neurobiology and neurochemistry , 2007, Progress in Neurobiology.

[62]  Yu-Chung N. Cheng,et al.  Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.

[63]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[64]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[65]  R. Grossman,et al.  Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging , 2009, Journal of magnetic resonance imaging : JMRI.

[66]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[67]  J. Bulte,et al.  Direct saturation MRI: Theory and application to imaging brain iron , 2009, Magnetic resonance in medicine.

[68]  Douglas B. Kell,et al.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples , 2010, Archives of Toxicology.

[69]  W Craelius,et al.  Iron deposits surrounding multiple sclerosis plaques. , 1982, Archives of pathology & laboratory medicine.

[70]  J. Hardy,et al.  Iron accumulation in syndromes of neurodegeneration with brain iron accumulation 1 and 2: causative or consequential? , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[71]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[72]  I. Moseley,et al.  Signal intensity on MRI of basal ganglia in multiple sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[73]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[74]  Frederik Barkhof,et al.  No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[75]  J. Connor,et al.  Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains , 1990, Journal of neuroscience research.

[76]  Rohit Bakshi,et al.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. , 2005, Archives of neurology.